Kiora Pharmaceuticals News

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Kiora Pharmaceuticals (KPRX) and Actinium Pharmaceuticals (ATNM)

TipRanksMar 28 07:30 ET

Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX) and Genmab (GMAB)

TipRanksMar 27 06:30 ET

Kiora Pharmaceuticals Analyst Ratings

BenzingaMar 27 06:27 ET

Kiora Pharmaceuticals: Strong Buy Rating on Strategic Partnership and Promising Trial Results

TipRanksFeb 9 06:16 ET

Kiora Pharmaceuticals Analyst Ratings

BenzingaFeb 9 06:08 ET

Kiora Pharmaceuticals (KPRX) Receives a Buy From Maxim Group

TipRanksFeb 7 07:57 ET

Analysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS) and Kiora Pharmaceuticals (KPRX)

TipRanksNov 14, 2023 15:02 ET

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $3.5 Price Target

BenzingaNov 13, 2023 10:31 ET

Kiora Pharmaceuticals Analyst Ratings

BenzingaNov 13, 2023 10:29 ET

Promising Clinical Trials and Innovative Trajectory Bolsters Buy Rating for Kiora Pharmaceuticals

TipRanksNov 13, 2023 06:39 ET

Analysts Offer Insights on Healthcare Companies: Cassava Sciences (SAVA), Kiora Pharmaceuticals (KPRX) and Bluebird Bio (BLUE)

TipRanksNov 7, 2023 11:31 ET

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Raises Price Target to $3.5

BenzingaNov 6, 2023 06:42 ET

Kiora Pharmaceuticals Analyst Ratings

BenzingaNov 6, 2023 06:41 ET

Kiora Pharmaceuticals (KPRX) Receives a Buy From Maxim Group

TipRanksSep 15, 2023 10:55 ET

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $2 Price Target

BenzingaAug 24, 2023 06:24 ET

Kiora Pharmaceuticals Analyst Ratings

BenzingaAug 24, 2023 06:23 ET

H.C. Wainwright Sticks to Their Buy Rating for Kiora Pharmaceuticals (KPRX)

TipRanksAug 24, 2023 06:15 ET

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Lowers Price Target to $2

BenzingaAug 14, 2023 06:38 ET

Kiora Pharmaceuticals Analyst Ratings

BenzingaAug 14, 2023 06:37 ET

HC Wainwright Raises Kiora Pharmaceuticals' Price Target to $7 From $6, Maintains Buy Rating

MT NewswiresMay 12, 2023 08:02 ET